Coluracetam buy: A depth review of coluracetam benefits, dosage & side effects
Coluracetam history Coluracetam also known as BCI-540 or 2-(2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro2, 3-b quinolin-4-yl) acetoamide was formerly known as MKC-231. Coluracetam is a new synthetic nootropic from the racetam family however, it a strong nootropic compound in enhancing memory and general cognitive functioning. Coluracetam is essentially, a dietary supplement obtained from piracetam. Coluracetam was first developed by Mitsubishi Tanabe Pharma Corporation in 2005. They developed it as a potential treatment for Alzheimer’s disease. Although the preliminary results demonstrated some potential, they failed to reach the endpoints. Later the license was transferred to BrainCells Inc. which developed it for treatment of major depressive disorder (MDD) and general anxiety disorder (GAD). They reached phase 2a clinical studies that reported some potential in relieving patients from major depressive disorder as well as from anxiety....